Rapt Therapeutics (RAPT)
(Delayed Data from NSDQ)
$1.79 USD
-0.14 (-7.25%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.80 +0.01 (0.56%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.56 |
EPS Last Quarter | -0.71 |
Last EPS Surprise | 4.05% |
ABR | 2.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.73 |
Next Year | -1.98 |
EPS (TTM) | -3.12 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 1.53M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.56 | -0.46 | -2.73 | -1.98 |
# of Estimates | 5 | 5 | 6 | 5 |
Most Recent Consensus | -0.63 | -0.57 | -2.70 | -2.58 |
High Estimate | -0.45 | -0.40 | -2.26 | -1.62 |
Low Estimate | -0.64 | -0.57 | -4.12 | -2.58 |
Year ago EPS | -0.82 | -0.80 | -3.05 | -2.73 |
Year over Year Growth Est. | 31.71% | 42.50% | 10.49% | 27.45% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.56 | -0.46 | -2.73 | -1.98 |
7 Days Ago | -0.56 | -0.46 | -2.73 | -1.98 |
30 Days Ago | -0.56 | -0.46 | -2.73 | -1.98 |
60 Days Ago | -0.61 | -0.52 | -2.93 | -2.05 |
90 Days Ago | -0.61 | -0.52 | -2.93 | -2.05 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.56 | -0.46 | -2.73 | -1.98 |
Zacks Consensus Estimate | -0.56 | -0.46 | -2.73 | -1.98 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.71 | -0.79 | -0.80 | -0.82 | NA |
Estimate | -0.74 | -0.78 | -0.85 | -0.75 | NA |
Difference | 0.03 | -0.01 | 0.05 | -0.07 | 0.00 |
Surprise | 4.05% | -1.28% | 5.88% | -9.33% | -0.17% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more